Dare Bioscience, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Dare Bioscience, Inc. (DARE) reported Adjustments to Additional Paid in Capital, Warrant Issued of $182.98 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-03-31
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $182.98K, a 59.54% decline year-over-year.
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $215.11K, a 83.44% decline year-over-year.
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $8.11M.
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $452.19K, a 62.90% decline year-over-year.
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $834.51K, a 31.53% decline from fiscal 2022.
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $1.22M, a 143.68% increase from fiscal 2021.
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $500.15K, a 72.00% decline from fiscal 2020.
- Dare Bioscience, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $1.79M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2024-06-30 | $182.98K 10-Q · filed 2024-08-12 | $398.09K derived: sum of 2 quarters · filed 2024-08-12 | ||
| 2024-03-31 | $215.11K 10-Q · filed 2024-08-12 | |||
| 2023-12-31 | $834.51K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $8.11M 10-Q · filed 2023-11-09 | $8.56M derived: sum of 2 quarters · filed 2024-08-12 | $9.86M derived: sum of 3 quarters · filed 2024-08-12 | |
| 2023-06-30 | $452.19K 10-Q · filed 2024-08-12 | $1.75M derived: sum of 2 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $1.30M 10-Q · filed 2024-08-12 | |||
| 2022-12-31 | $1.22M 10-K · filed 2024-03-28 | |||
| 2022-06-30 | $1.22M 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $500.15K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $204.47K 10-Q · filed 2022-11-10 | |||
| 2021-03-31 | $50.40K 10-Q · filed 2022-11-10 | |||
| 2020-12-31 | $1.79M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $120.96K 10-Q · filed 2021-11-10 | |||
| 2020-03-31 | $1.67M 10-Q · filed 2021-11-10 | |||
| 2014-06-30 | $424.00K 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |